In this webinar, youll learn: About the science behind GLP-1sand the data around how theyre impacting employers How thoughtfully structured weight management plans can balance costs with outcomes What benefits our SmithRx program offers in collaboration with 9amHealth Speakers Alissa Johnson, PharmD, MBA, BCPS Senior Director, Clinical Strategy, SmithRx Avantika Waring, MD Chief Medical Officer, 9amHealth FAQ

Molecular Composition and Characteristics Component 1: BPC-157 (synthetic pentadecapeptide) Component 2: TB-500 (thymosin beta-4 analogue) Structure: Linear synthetic peptide chains supplied as a blended formulation Dose Format: High-concentration 20mg blended vial Stability: High under recommended laboratory storage conditions Stability, Handling, and Storage Profile Supplied as a lyophilised powder for optimal long-term stability Recommended storage temperature: 20C Sensitive to moisture, oxygen, and prolonged light exposure Predictable degradation at elevated temperatures Reconstituted solutions typically stable for 2448 hours under refrigeration Solubility and Reconstitution Options Bacteriostatic water Sterile saline solutions Acidic buffer systems Compatible organic analytical solvents Technical Specifications product Name BPC-157 + TB-500 Blend 20mg cas 137525-51-0, 77591-33-4 purity 99% (HPLC verified) unit Size 20 mg blended vial form Lyophilised peptide blend synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic peptide chains stability High when stored under recommended conditions Analytical Validation and Quality Control HPLC purity confirmation for each peptide component Mass Spectrometry molecular identity verification UV spectrophotometric concentration analysis Batch consistency and reproducibility testing Endotoxin and microbial screening for regulated laboratory use Regulatory Status and Intended Use BPC-157 + TB-500 Blend 20mg is supplied strictly for laboratory research and in-vitro scientific investigation

[1] Other safety considerations include risk of gallbladder disease, pancreatitis, diabetic retinopathy complications (particularly with rapid A1c reduction), and hypersensitivity reactions
Immunobiology 218:10261033
Three timing ideas recur, all traceable to GH physiology, and all better supported in principle than any specific dose figure though still, it must be said, not validated for this blend in humans
220 , 119123 (2015) V.L